Oncology & Cancer

Impact of recurrence score assay varies with patient age

(HealthDay)—For women with early-stage breast cancer, the impact of receipt of the 21-gene recurrence score (RS) assay varies with patient age, according to a study published online Nov. 23 in the Journal of Clinical Oncology.

Oncology & Cancer

Drug might help breast cancer patients avoid heart damage

Many cancer treatments have a dark side—they can damage the heart. New research suggests this risk might be lowered in women with breast tumors if they take a heart drug as a preventive measure during their cancer care.

Oncology & Cancer

Study examines cancer-care outcomes among US hospitals

Decades of research have shown that cancer survival outcomes can vary widely depending on where patients receive care. But efforts to rank hospitals by long-term survival rates have been hindered by the readily available ...

Oncology & Cancer

Gene test finds which breast cancer patients can skip chemo

Many women with early-stage breast cancer can skip chemotherapy without hurting their odds of beating the disease—good news from a major study that shows the value of a gene-activity test to gauge each patient's risk.

Oncology & Cancer

Physicians' peers influence use of new cancer Tx modalities

(HealthDay)—Physicians whose peers were early adopters of brachytherapy for the treatment of women with early-stage breast cancer are more likely to adopt the therapy themselves, according to a study published in the Aug. ...

page 22 from 30